REQUEST A DEMO
Total
USD $0.00
Search more companies

Ortosens Sp. z o.o. (Poland)

Main Activities: Pharmacies and Drug Stores
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Ortosens Sp. z o.o. Profile Updated: January 06, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Ortosens Sp. z o.o. is based in Poland. The head office is in Krakow. It operates in the Pharmacies and Drug Stores industry. It was established on October 06, 2021. From the latest financial highlights, Ortosens Sp. z o.o. reported a net sales revenue increase of 58.11% in 2024. There was a total growth of 237.24% in Ortosens Sp. z o.o.’s total assets over the same period. The net profit margin of Ortosens Sp. z o.o. increased by 2.88% in 2024.

Headquarters
Ul. Alberta Schweitzera 13
Krakow; Malopolskie; Postal Code: 30-695

Contact Details: Purchase the Ortosens Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Ortosens Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Ortosens Sp. z o.o. report to view the information.
Incorporation Date:
October 06, 2021
Key Executives
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
75%
Purchase this report to view the information.
25%
Company Performance
Financial values in the chart are available after Ortosens Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
58.11%
Total operating revenue
58.25%
Operating profit (EBIT)
177.84%
EBITDA
181.64%
Net Profit (Loss) for the Period
178.21%
Total Assets
237.24%
Total Equity
233.2%
Operating Profit Margin (ROS)
3.16%
Net Profit Margin
2.88%
Return on Equity (ROE)
-13.83%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?